Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Disulfides × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 21 Carcinoma, Non-Small-Cell Lung 15 Ovarian Neoplasms 11 Fallopian Tube Neoplasms 11 Colorectal Neoplasms 8 Urinary Bladder Neoplasms 6 Pancreatic Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Carcinoma, Hepatocellular 6 Mycosis Fungoides 5 Melanoma 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Lymphoma, T-Cell, Cutaneous 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Breast Neoplasms 4 Sezary Syndrome 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Lymphoma, T-Cell 3 Lymphoma, B-Cell 3 Carcinoma 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2

Interventions

Doxorubicin 6 pembrolizumab 4 eribulin 3 Specimen Handling 3 Radiotherapy 3 pazopanib 2 palbociclib 2 brigimadlin 2 abemaciclib 2 Radiation 2 Ifosfamide 2 Biopsy 2 zimberelimab 1 talimogene laherparepvec 1 sotigalimab 1 silmitasertib 1 selinexor 1 ribociclib 1 olaratumab 1 olaparib 1 mirdametinib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 durvalumab 1 avelumab 1 X-Rays 1 Vincristine 1 Trabectedin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡